Omnicell Inc represents a strong commitment to improving patient care and safety through innovative medication management solutions. The company's corporate philosophy revolves around optimizing workflows and ensuring the right medication is delivered to the right patient at the right time. Omnicell is dedicated to enhancing operational efficiency, reducing medication errors, and promoting adherence to medication regimens. Their values include prioritizing patient-centricity, fostering a culture of collaboration, and driving continuous innovation in healthcare technology. Omnicell Inc strives to revolutionize medication management processes, ultimately helping healthcare organizations deliver better patient outcomes and improve overall healthcare efficiency.

Omnicell Inc is primarily present in the United States.

Omnicell Inc has achieved several significant milestones since its inception. The company has become a global leader in automated healthcare solutions, catering to hospitals, pharmacies, and healthcare organizations. Omnicell's product portfolio includes advanced medication management systems, robotics, and software solutions improving patient safety and operational efficiency. The company has successfully expanded its global presence, established strategic partnerships, and received multiple industry accolades. Moreover, Omnicell has consistently focused on research and development, resulting in innovative technologies and improved patient outcomes. With its dedication to advancing healthcare through technology, Omnicell Inc continues to drive positive change in the industry.

Omnicell Inc, a leading provider of medication management solutions, has a rich history and background. Established in 1992, Omnicell has continuously delivered innovative technologies to enhance patient safety and improve healthcare outcomes. The company's journey started with automated dispensing systems for medication storage and administration. Over the years, Omnicell expanded its product portfolio to include advanced solutions like robotic automation, analytics, and interoperability, catering to various healthcare settings globally. Today, Omnicell is renowned for its commitment to optimizing medication management processes, reducing errors, improving efficiency, and enabling healthcare professionals to focus on patient care. With a strong track record and dedication to innovation, Omnicell Inc has established itself as a trusted name in the healthcare industry.

Omnicell Inc faces competition from various companies in the market. Some of its main competitors include McKesson Corporation, BD (Becton, Dickinson and Company), and Cantel Medical Corp. These companies operate in the healthcare solutions industry and provide similar products and services, which directly compete with Omnicell Inc. Additionally, companies like Capsa Healthcare and Baxter International Inc. also pose competition in certain segments. However, Omnicell Inc's strong market presence, innovative technologies, and comprehensive range of solutions help them remain competitive in the industry.

Omnicell Inc is primarily active in the healthcare industry.

Omnicell Inc is a leading healthcare technology company specializing in medication and supply management solutions. The company's business model revolves around providing automated systems and software solutions to hospitals, pharmacies, and other healthcare institutions. Omnicell aims to streamline workflow, improve patient safety, and optimize inventory management through its innovative technology and services. By offering a comprehensive suite of products, including medication dispensing cabinets, inventory management systems, and analytics software, Omnicell enhances operational efficiency and patient care quality. With its patient-centric approach, Omnicell Inc continues to be a trusted partner in the healthcare industry, delivering valuable solutions and improving overall healthcare outcomes.

Коефициентът на цена спрямо печалбата (КЦП) на Omnicell е 22,64.

Коефициентът на цена към оборот (KUV) на Omnicell е 1,09.

AlleAktien качественият резултат за Omnicell е 4/10.

очаквана Omnicell оборотът е 1,09 млрд. USD.

очаквана Omnicell печалба е 52,49 млн. USD.

Omnicell Inc. is a US-based company that has gained worldwide recognition for its automation solutions for healthcare providers. The company positions itself as a reliable provider of innovative products and services in this field. The main products and services of Omnicell Inc. fall into four main areas: medication management, central pharmacy systems, workflow optimization, and analytics solutions. The medication management is the core of Omnicell Inc.'s business model. The company offers a variety of solutions for various areas including hospitals, pharmacies, and long-term care facilities to better automate medication inspection, preparation, dispensing, and returns. These solutions help nursing staff save time, minimize errors, and better meet patient needs. Central pharmacy systems are another important pillar of Omnicell Inc. These systems are designed to automate the workflow of pharmacies and distribution centers by monitoring and managing inventory and orders, optimizing product assignment to patients, and providing real-time data for inventory management. Workflow optimization is an important aspect of Omnicell Inc.'s business model. The company aims to increase the efficiency of nursing staff by automating workflows, reducing workload, and improving the quality of patient care. The company has developed a wide range of solutions for this purpose, including automated documentation, inventory management, and patient assignment. Analytics solutions also play an important role in Omnicell Inc.'s business strategy. The company offers innovative analysis tools that monitor prescription dispensing and collect data to optimize medication inventory and orders. These tools provide important business-relevant information that contributes to higher ROI in the healthcare industry. Overall, the company offers a wide range of products and services aimed at increasing efficiency, accuracy, and effectiveness in healthcare. Omnicell Inc. aims to meet the needs of providers and patients alike while ensuring the highest level of reliability, efficiency, and safety. With its innovative products, strong focus on customer service, and continuous investment in research and development, Omnicell Inc. has established itself as a market leader in automation solutions for healthcare providers.

Omnicell разпределя дивидента от 0 USD на плащания годишно.

Дивидентата за Omnicell в момента не може да бъде изчислена или компанията не разпределя дивиденти.

ISIN на Omnicell е US68213N1090.

WKN на Omnicell е 632313.

Тикерът на Omnicell е OMCL.

През последните 12 месеца Omnicell изплати дивиденда в размер на . Това съответства на дивидендна доходност от около . За следващите 12 месеца се очаква Omnicell да изплати дивиденда в размер на 0 USD.

Дивидентната доходност на Omnicell в момента е .

Omnicell изплаща дивидент на тримесечие. Той се разпределя в месеците .

Omnicell платеше дивиденда всяка година през последните 0 години.

За идните 12 месеца се очакват дивиденти в размер на 0 USD. Това съответства на дивидентна доходност от 0 %.

Omnicell се отнася за сектор 'Здраве'.

За да получите последното дивидентно плащане от Omnicell на 12.07.2024 г. в размер на 0 USD, трябваше да притежавате акцията в портфейла си преди Ex-деня на 12.07.2024 г..

Последното дивидентно плащане беше извършено на 12.07.2024 г..

През година 2023 Omnicell изплати 0 USD под формата на дивиденти.

Дивидентите от Omnicell се изплащат в USD.